US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 37.010
  • -0.650-1.73%
Close Aug 9 16:00 ET
  • 37.010
  • 0.0000.00%
Post 20:01 ET
4.51BMarket Cap-13606P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-41.57%360.09M
-57.40%325.92M
-36.36%351.19M
-36.36%351.19M
-36.15%452.41M
-27.74%616.26M
-20.74%765.08M
-21.23%551.8M
-21.23%551.8M
64.66%708.55M
-Cash and cash equivalents
-41.57%360.09M
-57.40%325.92M
-36.36%351.19M
-36.36%351.19M
-22.56%452.41M
1.95%616.26M
20.78%765.08M
-13.81%551.8M
-13.81%551.8M
105.89%584.19M
-Short-term investments
----
----
----
----
----
----
----
----
----
-15.15%124.36M
Receivables
140.73%308.85M
764.42%272.34M
492.65%224.5M
492.65%224.5M
2,211.07%186.99M
1,606.56%128.3M
397.71%31.51M
274.94%37.88M
274.94%37.88M
129.73%8.09M
-Accounts receivable
174.48%304.43M
750.14%267.84M
2,571.70%206.44M
2,571.70%206.44M
1,991.93%169.26M
1,375.30%110.91M
397.71%31.51M
-23.52%7.73M
-23.52%7.73M
129.73%8.09M
-Taxes receivable
----
----
--0
--0
--0
--0
----
--8.71M
--8.71M
----
-Other receivables
-74.59%4.42M
--4.5M
-15.80%18.05M
-15.80%18.05M
--17.73M
--17.39M
----
--21.44M
--21.44M
----
Inventory
48.01%152.77M
88.67%161.28M
70.76%146.36M
70.76%146.36M
64.92%98.55M
113.03%103.22M
160.23%85.48M
426.30%85.71M
426.30%85.71M
3,463.09%59.75M
Prepaid assets
-15.79%28.97M
18.06%43.16M
6.80%38.82M
6.80%38.82M
46.98%44.62M
60.18%34.4M
49.01%36.56M
46.17%36.35M
46.17%36.35M
74.72%30.36M
Restricted cash
23.41%1.34M
-13.49%1.1M
-12.49%1.11M
-12.49%1.11M
-13.74%1.09M
-14.30%1.09M
-18.16%1.28M
-18.55%1.27M
-18.55%1.27M
-19.45%1.26M
Other current assets
-15.59%7.95M
-77.82%7.62M
-33.07%4.35M
-33.07%4.35M
-45.18%13.12M
-66.89%9.42M
-53.21%34.35M
-90.80%6.51M
-90.80%6.51M
14.04%23.93M
Total current assets
-3.66%859.97M
-14.97%811.43M
6.51%766.33M
6.51%766.33M
-4.23%796.77M
-7.01%892.69M
-13.56%954.26M
-12.68%719.52M
-12.68%719.52M
74.99%831.94M
Non current assets
Net PPE
-8.65%20.16M
-19.45%19.19M
-15.28%21.09M
-15.28%21.09M
-19.56%20.27M
-17.20%22.07M
-7.90%23.82M
-4.54%24.9M
-4.54%24.9M
-8.15%25.2M
-Gross PPE
-8.65%20.16M
-19.45%19.19M
-15.28%21.09M
-15.28%21.09M
-19.56%20.27M
-17.20%22.07M
-7.90%23.82M
-4.54%24.9M
-4.54%24.9M
-8.15%25.2M
Other non current assets
2,844.50%24.35M
65.57%1.31M
-91.71%1.31M
-91.71%1.31M
-92.54%1.18M
-94.79%827K
-95.05%793K
-50.07%15.8M
-50.07%15.8M
-30.98%15.75M
Total non current assets
94.43%44.51M
-16.71%20.5M
-44.96%22.4M
-44.96%22.4M
-47.63%21.45M
-46.17%22.89M
-41.22%24.61M
-29.50%40.69M
-29.50%40.69M
-18.52%40.96M
Total assets
-1.21%904.48M
-15.01%831.93M
3.75%788.73M
3.75%788.73M
-6.26%818.22M
-8.67%915.58M
-14.57%978.87M
-13.78%760.22M
-13.78%760.22M
66.05%872.89M
Liabilities
Current liabilities
Payables
39.16%38.27M
-14.94%26.79M
0.47%37.52M
0.47%37.52M
29.03%18.19M
69.54%27.5M
156.61%31.49M
120.84%37.34M
120.84%37.34M
182.89%14.1M
-accounts payable
39.16%38.27M
-14.94%26.79M
0.47%37.52M
0.47%37.52M
29.03%18.19M
69.54%27.5M
156.61%31.49M
120.84%37.34M
120.84%37.34M
182.89%14.1M
Current accrued expenses
2.42%100.08M
42.31%101.4M
34.34%127.81M
34.34%127.81M
46.77%117.09M
9.28%97.72M
-32.32%71.25M
-7.85%95.14M
-7.85%95.14M
14.22%79.78M
Current provisions
--22.7M
----
----
----
----
----
----
----
----
----
Current debt and capital lease obligation
6.19%6.21M
7.36%6.26M
14.51%6.44M
14.51%6.44M
5.83%5.74M
10.17%5.85M
27.81%5.83M
36.70%5.63M
36.70%5.63M
33.18%5.42M
-Current capital lease obligation
6.19%6.21M
7.36%6.26M
14.51%6.44M
14.51%6.44M
5.83%5.74M
10.17%5.85M
27.81%5.83M
36.70%5.63M
36.70%5.63M
33.18%5.42M
Current deferred liabilities
--1.9M
--3.56M
----
----
----
----
----
----
----
----
Other current liabilities
----
157.02%77.29M
157.02%75.83M
157.02%75.83M
176.29%44.61M
176.28%43.77M
1,028.79%30.07M
289.03%29.5M
289.03%29.5M
5.30%16.15M
Current liabilities
-3.24%169.17M
55.28%215.29M
47.72%247.59M
47.72%247.59M
60.79%185.63M
37.89%174.84M
11.12%138.64M
27.12%167.61M
27.12%167.61M
22.51%115.45M
Non current liabilities
Long term debt and capital lease obligation
346.21%468.3M
-2.98%102.88M
-2.43%104.49M
-2.43%104.49M
-3.81%103.84M
-49.05%104.95M
-48.49%106.04M
-48.04%107.09M
-48.04%107.09M
-48.04%107.95M
-Long term debt
392.24%457.21M
0.32%93.11M
0.32%93.03M
0.32%93.03M
0.32%92.96M
-50.94%92.88M
-50.94%92.81M
-50.94%92.74M
-50.94%92.74M
-51.13%92.66M
-Long term capital lease obligation
-8.13%11.09M
-26.17%9.77M
-20.19%11.45M
-20.19%11.45M
-28.83%10.88M
-27.64%12.07M
-20.71%13.23M
-15.98%14.35M
-15.98%14.35M
-15.77%15.29M
Other non current liabilities
-99.07%2.69M
-23.28%247.08M
-23.29%242.13M
-23.29%242.13M
-13.33%296.48M
-13.39%290.39M
-8.76%322.06M
-8.55%315.65M
-8.55%315.65M
--342.08M
Total non current liabilities
19.14%470.99M
-18.25%349.96M
-18.01%346.62M
-18.01%346.62M
-11.05%400.32M
-26.96%395.34M
-23.40%428.1M
-23.31%422.74M
-23.31%422.74M
-7.93%450.03M
Total liabilities
12.27%640.16M
-0.26%565.25M
0.65%594.21M
0.65%594.21M
3.62%585.95M
-14.65%570.18M
-17.10%566.75M
-13.58%590.35M
-13.58%590.35M
-3.01%565.48M
Shareholders'equity
Share capital
0.00%12K
0.00%12K
9.09%12K
9.09%12K
9.09%12K
9.09%12K
9.09%12K
10.00%11K
10.00%11K
22.22%11K
-common stock
0.00%12K
0.00%12K
9.09%12K
9.09%12K
9.09%12K
9.09%12K
9.09%12K
10.00%11K
10.00%11K
22.22%11K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-12.76%-2.94B
-16.78%-2.9B
-22.90%-2.84B
-22.90%-2.84B
-28.28%-2.75B
-33.67%-2.61B
-38.48%-2.49B
-39.37%-2.31B
-39.37%-2.31B
-42.03%-2.14B
Paid-in capital
8.61%3.21B
9.47%3.17B
22.42%3.04B
22.42%3.04B
21.56%2.98B
29.08%2.95B
28.30%2.9B
33.50%2.48B
33.50%2.48B
68.79%2.45B
Gains losses not affecting retained earnings
-322.36%-3.36M
-354.84%-3.53M
-304.80%-3.54M
-304.80%-3.54M
64.82%-1.07M
75.08%-796K
62.36%-775K
58.13%-875K
58.13%-875K
-50.60%-3.03M
Total stockholders'equity
-23.47%264.33M
-35.29%266.68M
14.51%194.52M
14.51%194.52M
-24.44%232.27M
3.28%345.4M
-10.84%412.12M
-14.49%169.87M
-14.49%169.87M
636.27%307.42M
Total equity
-23.47%264.33M
-35.29%266.68M
14.51%194.52M
14.51%194.52M
-24.44%232.27M
3.28%345.4M
-10.84%412.12M
-14.49%169.87M
-14.49%169.87M
636.27%307.42M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -41.57%360.09M-57.40%325.92M-36.36%351.19M-36.36%351.19M-36.15%452.41M-27.74%616.26M-20.74%765.08M-21.23%551.8M-21.23%551.8M64.66%708.55M
-Cash and cash equivalents -41.57%360.09M-57.40%325.92M-36.36%351.19M-36.36%351.19M-22.56%452.41M1.95%616.26M20.78%765.08M-13.81%551.8M-13.81%551.8M105.89%584.19M
-Short-term investments -------------------------------------15.15%124.36M
Receivables 140.73%308.85M764.42%272.34M492.65%224.5M492.65%224.5M2,211.07%186.99M1,606.56%128.3M397.71%31.51M274.94%37.88M274.94%37.88M129.73%8.09M
-Accounts receivable 174.48%304.43M750.14%267.84M2,571.70%206.44M2,571.70%206.44M1,991.93%169.26M1,375.30%110.91M397.71%31.51M-23.52%7.73M-23.52%7.73M129.73%8.09M
-Taxes receivable ----------0--0--0--0------8.71M--8.71M----
-Other receivables -74.59%4.42M--4.5M-15.80%18.05M-15.80%18.05M--17.73M--17.39M------21.44M--21.44M----
Inventory 48.01%152.77M88.67%161.28M70.76%146.36M70.76%146.36M64.92%98.55M113.03%103.22M160.23%85.48M426.30%85.71M426.30%85.71M3,463.09%59.75M
Prepaid assets -15.79%28.97M18.06%43.16M6.80%38.82M6.80%38.82M46.98%44.62M60.18%34.4M49.01%36.56M46.17%36.35M46.17%36.35M74.72%30.36M
Restricted cash 23.41%1.34M-13.49%1.1M-12.49%1.11M-12.49%1.11M-13.74%1.09M-14.30%1.09M-18.16%1.28M-18.55%1.27M-18.55%1.27M-19.45%1.26M
Other current assets -15.59%7.95M-77.82%7.62M-33.07%4.35M-33.07%4.35M-45.18%13.12M-66.89%9.42M-53.21%34.35M-90.80%6.51M-90.80%6.51M14.04%23.93M
Total current assets -3.66%859.97M-14.97%811.43M6.51%766.33M6.51%766.33M-4.23%796.77M-7.01%892.69M-13.56%954.26M-12.68%719.52M-12.68%719.52M74.99%831.94M
Non current assets
Net PPE -8.65%20.16M-19.45%19.19M-15.28%21.09M-15.28%21.09M-19.56%20.27M-17.20%22.07M-7.90%23.82M-4.54%24.9M-4.54%24.9M-8.15%25.2M
-Gross PPE -8.65%20.16M-19.45%19.19M-15.28%21.09M-15.28%21.09M-19.56%20.27M-17.20%22.07M-7.90%23.82M-4.54%24.9M-4.54%24.9M-8.15%25.2M
Other non current assets 2,844.50%24.35M65.57%1.31M-91.71%1.31M-91.71%1.31M-92.54%1.18M-94.79%827K-95.05%793K-50.07%15.8M-50.07%15.8M-30.98%15.75M
Total non current assets 94.43%44.51M-16.71%20.5M-44.96%22.4M-44.96%22.4M-47.63%21.45M-46.17%22.89M-41.22%24.61M-29.50%40.69M-29.50%40.69M-18.52%40.96M
Total assets -1.21%904.48M-15.01%831.93M3.75%788.73M3.75%788.73M-6.26%818.22M-8.67%915.58M-14.57%978.87M-13.78%760.22M-13.78%760.22M66.05%872.89M
Liabilities
Current liabilities
Payables 39.16%38.27M-14.94%26.79M0.47%37.52M0.47%37.52M29.03%18.19M69.54%27.5M156.61%31.49M120.84%37.34M120.84%37.34M182.89%14.1M
-accounts payable 39.16%38.27M-14.94%26.79M0.47%37.52M0.47%37.52M29.03%18.19M69.54%27.5M156.61%31.49M120.84%37.34M120.84%37.34M182.89%14.1M
Current accrued expenses 2.42%100.08M42.31%101.4M34.34%127.81M34.34%127.81M46.77%117.09M9.28%97.72M-32.32%71.25M-7.85%95.14M-7.85%95.14M14.22%79.78M
Current provisions --22.7M------------------------------------
Current debt and capital lease obligation 6.19%6.21M7.36%6.26M14.51%6.44M14.51%6.44M5.83%5.74M10.17%5.85M27.81%5.83M36.70%5.63M36.70%5.63M33.18%5.42M
-Current capital lease obligation 6.19%6.21M7.36%6.26M14.51%6.44M14.51%6.44M5.83%5.74M10.17%5.85M27.81%5.83M36.70%5.63M36.70%5.63M33.18%5.42M
Current deferred liabilities --1.9M--3.56M--------------------------------
Other current liabilities ----157.02%77.29M157.02%75.83M157.02%75.83M176.29%44.61M176.28%43.77M1,028.79%30.07M289.03%29.5M289.03%29.5M5.30%16.15M
Current liabilities -3.24%169.17M55.28%215.29M47.72%247.59M47.72%247.59M60.79%185.63M37.89%174.84M11.12%138.64M27.12%167.61M27.12%167.61M22.51%115.45M
Non current liabilities
Long term debt and capital lease obligation 346.21%468.3M-2.98%102.88M-2.43%104.49M-2.43%104.49M-3.81%103.84M-49.05%104.95M-48.49%106.04M-48.04%107.09M-48.04%107.09M-48.04%107.95M
-Long term debt 392.24%457.21M0.32%93.11M0.32%93.03M0.32%93.03M0.32%92.96M-50.94%92.88M-50.94%92.81M-50.94%92.74M-50.94%92.74M-51.13%92.66M
-Long term capital lease obligation -8.13%11.09M-26.17%9.77M-20.19%11.45M-20.19%11.45M-28.83%10.88M-27.64%12.07M-20.71%13.23M-15.98%14.35M-15.98%14.35M-15.77%15.29M
Other non current liabilities -99.07%2.69M-23.28%247.08M-23.29%242.13M-23.29%242.13M-13.33%296.48M-13.39%290.39M-8.76%322.06M-8.55%315.65M-8.55%315.65M--342.08M
Total non current liabilities 19.14%470.99M-18.25%349.96M-18.01%346.62M-18.01%346.62M-11.05%400.32M-26.96%395.34M-23.40%428.1M-23.31%422.74M-23.31%422.74M-7.93%450.03M
Total liabilities 12.27%640.16M-0.26%565.25M0.65%594.21M0.65%594.21M3.62%585.95M-14.65%570.18M-17.10%566.75M-13.58%590.35M-13.58%590.35M-3.01%565.48M
Shareholders'equity
Share capital 0.00%12K0.00%12K9.09%12K9.09%12K9.09%12K9.09%12K9.09%12K10.00%11K10.00%11K22.22%11K
-common stock 0.00%12K0.00%12K9.09%12K9.09%12K9.09%12K9.09%12K9.09%12K10.00%11K10.00%11K22.22%11K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -12.76%-2.94B-16.78%-2.9B-22.90%-2.84B-22.90%-2.84B-28.28%-2.75B-33.67%-2.61B-38.48%-2.49B-39.37%-2.31B-39.37%-2.31B-42.03%-2.14B
Paid-in capital 8.61%3.21B9.47%3.17B22.42%3.04B22.42%3.04B21.56%2.98B29.08%2.95B28.30%2.9B33.50%2.48B33.50%2.48B68.79%2.45B
Gains losses not affecting retained earnings -322.36%-3.36M-354.84%-3.53M-304.80%-3.54M-304.80%-3.54M64.82%-1.07M75.08%-796K62.36%-775K58.13%-875K58.13%-875K-50.60%-3.03M
Total stockholders'equity -23.47%264.33M-35.29%266.68M14.51%194.52M14.51%194.52M-24.44%232.27M3.28%345.4M-10.84%412.12M-14.49%169.87M-14.49%169.87M636.27%307.42M
Total equity -23.47%264.33M-35.29%266.68M14.51%194.52M14.51%194.52M-24.44%232.27M3.28%345.4M-10.84%412.12M-14.49%169.87M-14.49%169.87M636.27%307.42M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Gene Editing
Gene Editing
Intraday+0.23%
Top Gainers Yesterday
Top Gainers Yesterday
Intraday-4.29%